# AlphaGen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alphagen

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.alphagentx.com
- Latest round: Seed (Oct 18, 2023)
- Investors on record: 1

## About

Based in Shanghai, China, and founded in 2022, AlphaGen is a pharmaceutical company that focuses on the development of the field of radiopharmaceuticals. In October 2023, AlphaGen raised seed funding led by new investor Eight Roads Ventures. The company's co-founder, Professor Zhen Cheng, is a director of the Molecular Imaging Center of the Chinese Academy of Sciences Shanghai Institute of Materia Medica (SIMM). July 2025, AlphaGen closed a series A funding. The company is committed to developing alpha and beta radio ligand therapies. It has developed Pb-212 isolation technology which can build a radiopharmaceutical platform. The company will use the funds to promote the clinical development of the Pb-212 pipeline and build a radioactive drug research and development technology platform and pipeline.

## Funding rounds

- Seed, Oct 18, 2023 — Eight Roads Ventures

## Investors

- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Seed